BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
Sep. 27, 2000
View Archived Issues
Peptide Alliance With Baxter Puts End To Merger Talks With Cantab
Read More
Scotia Suffers Setback As Foscan Deemed Not Approvable By FDA
Read More
XTL Raises $44M In London IPO; Company Value Grows To $230M
Read More
Genmab Seeks EUR240M In Dual Neuer Markt, Copenhagen IPO
Read More
Other News To Note
Read More
Stem Cells From Brain Can Form Muscle Cells, Italian Study Shows
Read More
Pantheco Reports Progress With AntiSense Antibiotics
Read More
Meristem Completes Phase I Of Plant Engineered-Derived Drug
Read More
Oxford Glyco Seeks Added Nasdaq Listing For U.S. Deals
Read More
EU Committee Shoots Down Italian Concerns Over GM Food
Read More
NIH Funds Study Of NicOx Drugs For Cancer Indications
Read More
Syn X Pharma Expands Efforts From Diagnostics To Cardiac Therapeutics
Read More
EU Group Makes Progress In Alliance For Rare Diseases
Read More